These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11835236)

  • 1. Preliminary results of dose intensive pre-irradiation chemotherapy in patients older than 10 years of age with high risk medulloblastoma and supratentorial primitive neuroectodermal tumors.
    Dhodapkar K; Dunkel IJ; Gardner S; Sapp M; Thoron L; Finlay J
    Med Pediatr Oncol; 2002 Jan; 38(1):47-8. PubMed ID: 11835236
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
    Sung KW; Yoo KH; Cho EJ; Koo HH; Lim DH; Shin HJ; Ahn SD; Ra YS; Choi ES; Ghim TT
    Pediatr Blood Cancer; 2007 Apr; 48(4):408-15. PubMed ID: 17066462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931).
    Allen J; Donahue B; Mehta M; Miller DC; Rorke LB; Jakacki R; Robertson P; Sposto R; Holmes E; Vezina G; Muraszko K; Puccetti D; Prados M; Chan KW
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1006-11. PubMed ID: 19356859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study.
    Sawamura Y; Ikeda J; Ishii N; Kato T; Tada M; Abe H; Shirato H
    Neurol Med Chir (Tokyo); 1996 Sep; 36(9):632-8. PubMed ID: 8913079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031).
    Tarbell NJ; Friedman H; Polkinghorn WR; Yock T; Zhou T; Chen Z; Burger P; Barnes P; Kun L
    J Clin Oncol; 2013 Aug; 31(23):2936-41. PubMed ID: 23857975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation?
    Biswas S; Burke A; Cherian S; Williams D; Nicholson J; Horan G; Jefferies S; Williams M; Earl HM; Burnet NG; Hatcher H
    Pediatr Blood Cancer; 2009 Jul; 52(7):796-803. PubMed ID: 19202566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive disease in children with medulloblastoma/PNET during preradiation chemotherapy.
    Tornesello A; Mastrangelo S; Piciacchia D; Bembo V; Colosimo C; Di Rocco C; Mastrangelo R
    J Neurooncol; 1999; 45(2):135-40. PubMed ID: 10778729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
    Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
    J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas.
    Terterov S; Krieger MD; Bowen I; McComb JG
    J Neurosurg Pediatr; 2010 Aug; 6(2):131-6. PubMed ID: 20672933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study.
    Taylor RE; Bailey CC; Robinson K; Weston CL; Ellison D; Ironside J; Lucraft H; Gilbertson R; Tait DM; Walker DA; Pizer BL; Imeson J; Lashford LS; ;
    J Clin Oncol; 2003 Apr; 21(8):1581-91. PubMed ID: 12697884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.
    Strother D; Ashley D; Kellie SJ; Patel A; Jones-Wallace D; Thompson S; Heideman R; Benaim E; Krance R; Bowman L; Gajjar A
    J Clin Oncol; 2001 May; 19(10):2696-704. PubMed ID: 11352962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91.
    Timmermann B; Kortmann RD; Kühl J; Meisner C; Dieckmann K; Pietsch T; Bamberg M
    J Clin Oncol; 2002 Feb; 20(3):842-9. PubMed ID: 11821469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose reductions of vincristine in children with medulloblastoma treated in the maintenance arm of the prospective multicenter trial HIT'91.
    von Bueren AO; von Hoff K; Benesch M; Rutkowski S
    Klin Padiatr; 2009; 221(6):396-7. PubMed ID: 19890797
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of high-dose chemotherapy and stem cell rescue in the treatment of malignant brain tumors.
    Finlay JL
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S1-5. PubMed ID: 8971398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of patients of high-risk group of medulloblastoma with the adjuvant lomustine, cisplatin, and vincristine chemotherapy.
    Rutkauskiene G; Labanauskas L
    Medicina (Kaunas); 2005; 41(12):1026-34. PubMed ID: 16401959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preradiation chemotherapy in advanced medulloblastoma. A Pediatric Oncology Group pilot study.
    Mosijczuk AD; Nigro MA; Thomas PR; Burger PC; Krischer JP; Morantz RA; Kurdunowicz B; Mulne AF; Towbin RB; Freeman AI
    Cancer; 1993 Nov; 72(9):2755-62. PubMed ID: 8402500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of early recurrent medulloblastoma in children with cisplatin and etoposide: a preliminary report.
    Kudo H; Kokunai T; Kuwamura K; Tamaki N; Sawa H; Izawa I; Tatsumi S; Hamano S; Matsumoto S
    Childs Nerv Syst; 1992 May; 8(3):133-5. PubMed ID: 1611612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Use of Dose Dense Neoadjuvant Chemotherapy and Sodium Valproate with Minimal Toxicity in an Infant with Medulloblastoma in Extremely Poor General Condition.
    Gupta A; Kumar A; Abrari A; Patir R; Vaishya S
    World Neurosurg; 2016 Sep; 93():485.e1-5. PubMed ID: 27450977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
    Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM
    J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.